Wilmington, Del. – September 15, 2026 -- The Chemours Company, along with DuPont de Nemours and Corteva, has agreed to pay $455 million over 15 years to settle PFAS-related litigation brought by the State of North Carolina and 11 local entities near the company's Fayetteville Works facility.
Chemours' share totals approximately $180 million on a net present value basis
Under a January 2021 memorandum of understanding, Chemours is responsible for 50% of settlement payments, with DuPont and Corteva covering the remaining half. Chemours said its portion is fully covered by existing accruals, with expected payments of approximately $50 million over the next twelve months.
Settlement resolves claims tied to Fayetteville Works and broader AFFF contamination
The agreement covers litigation from the State and 11 local entities -- including Bladen, Brunswick, Columbus, Cumberland, New Hanover, Robeson and Sampson counties, the City of Lumberton, Town of Wrightsville Beach, Village of Bald Head Island, and the Lower Cape Fear Water and Sewer Authority -- that were excluded from the 2024 U.S. Public Water System Class Settlement. Of the $455 million total, $18 million is attributed to alleged PFAS contamination unrelated to Fayetteville Works, including from aqueous film forming foam.
Deal credits progress under the 2019 Consent Order
The settlement acknowledges reductions in PFAS emissions from Fayetteville Works and mitigation of off-site impacts since 2019, while establishing procedures for remaining obligations, including drinking water programs. Several Consent Order provisions have already been completed, according to the company.
Chemours' escrow obligations under the MOU are now satisfied
Chemours, DuPont and Corteva reached new understandings on valuing the settlement for purposes of calculating qualified spend under the MOU, with the Settlement Amount counted at approximately $210 million on that basis. All future contributions to the MOU escrow account, including a $50 million payment that would have been due from Chemours in September 2026, are now considered satisfied. The Settlement Agreement remains subject to entry of dismissals in the covered litigations.